Arezoo Rastegari
Impact in
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
-
- Computational Drug Discovery Methods
Papers in
- Pharmacology 14
- Cholinesterase and Neurodegenerative Diseases 14
-
- Computational Drug Discovery Methods 8
- Co-authors
- Tahmineh Akbarzadeh (15 shared papers)Mina Saeedi (12 shared papers)Najmeh Edraki (5 shared papers)Seyedeh Sara Mirfazli (4 shared papers)Mohammad Mahdavi (4 shared papers)Omidreza Firuzi (5 shared papers)Farshad Homayouni Moghadam (3 shared papers)Roshanak Hariri (6 shared papers)
- Journals
- Archiv der Pharmazie (2 papers)Chemistry & Biodiversity (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)Molecular Diversity (2 papers)Bioorganic Chemistry (1 paper)
- Partner nations
- IranCanadaSaudi Arabia
In The Last Decade
Arezoo Rastegari
16 papers receiving 312 citations
Peers
Comparison fields: 5 of 46
- Pharmacology 180
- Computational Theory and Mathematics 137
- Organic Chemistry 174
- Complementary and alternative medicine 39
- Toxicology 8
Countries citing papers authored by Arezoo Rastegari
This map shows the geographic impact of Arezoo Rastegari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arezoo Rastegari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arezoo Rastegari more than expected).
Fields of papers citing papers by Arezoo Rastegari
This network shows the impact of papers produced by Arezoo Rastegari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arezoo Rastegari. The network helps show where Arezoo Rastegari may publish in the future.
Co-authors
The 25 scholars most cited alongside Arezoo Rastegari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 102 | |
| 2 | 2020 | 42 | |
| 3 | 2020 | 33 | |
| 4 | 2021 | 24 | |
| 5 | 2021 | 20 | |
| 6 | 2020 | 19 | |
| 7 | 2021 | 18 | |
| 8 | 2020 | 16 | |
| 9 | 2022 | 11 | |
| 10 | 2020 | 10 | |
| 11 | 2021 | 8 | |
| 12 | 2020 | 5 | |
| 13 | 2021 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 3 | |
| 16 | 2021 | 1 |
About Arezoo Rastegari
Arezoo Rastegari is a scholar working on Pharmacology, Computational Theory and Mathematics, Organic Chemistry, Molecular Biology and Rehabilitation, having authored 16 papers that have together received 319 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (14 papers), Computational Drug Discovery Methods (8 papers), Chemical synthesis and alkaloids (4 papers), Synthesis and biological activity (4 papers), Plant-derived Lignans Synthesis and Bioactivity (2 papers), Wound Healing and Treatments (2 papers), Medicinal Plants and Neuroprotection (2 papers) and Phytochemicals and Antioxidant Activities (1 paper). The work is most often cited by research in Pharmacology (180 citations), Computational Theory and Mathematics (137 citations), Organic Chemistry (174 citations), Complementary and alternative medicine (39 citations) and Toxicology (8 citations). Arezoo Rastegari has collaborated with scholars based in Iran, Canada and Saudi Arabia. Frequent co-authors include Tahmineh Akbarzadeh, Mina Saeedi, Najmeh Edraki, Seyedeh Sara Mirfazli, Mohammad Mahdavi, Omidreza Firuzi, Farshad Homayouni Moghadam, Roshanak Hariri, Alireza Moradi and Hamid Nadri. Their work appears in journals such as Archiv der Pharmazie, Chemistry & Biodiversity, Evidence-based Complementary and Alternative Medicine, Molecular Diversity and Bioorganic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.